ASCO 2026: Some breast cancer patients with sentinel lymph node spread can safely skip axillary lymph node dissection
Results from the phase 3 SENOMAC clinical trial found that omitting an axillary lymph node dissection (ALND)…
Results from the phase 3 SENOMAC clinical trial found that omitting an axillary lymph node dissection (ALND)…
Results from the phase III frontMIND trial show that adding tafasitamab and lenalidomide to R-CHOP…
Results from the first randomized controlled trial of a multi-cancer early detection (MCED) test suggest…
The CAPTURE breast cancer clinical trial has concluded that current standard of care, chemotherapy with…
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained…
A digital symptom monitoring program supported by palliative care nurses helped maintain quality of life…
At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) Andrew Wagner (Dana-Farber Cancer…
At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) David Reardon, MD, director…
Real-world data shows that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related…
For cancer survivors experiencing overall mood disturbance, anxiety, fatigue, or insomnia, regular gentle hatha and…